Filing Flows › Puma Biotechnology (PBYI) › How it makes money
How Puma Biotechnology (PBYI) makes money
Puma Biotechnology (PBYI) made $55.1M of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. Product revenue, net brought in $54.1M (98%); Royalty revenue brought in $1.0M (2%). Of every dollar of revenue, 10¢ was left as operating profit, 11¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product revenue, net | $54.1M | 98.2% | — | +4% |
| Royalty revenue | $1.0M | 1.8% | — | -62% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $55.1M | 100.0% |
| Operating profit | $5.3M | 9.6% |
| Income tax | $200K | 0.4% |
| Net earnings | $6.0M | 10.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $55.1M | +1% |
| Q2 2026 | $56.5M | +8% |
| Q1 2026 | $44.8M | -3% |
| Q4 2025 | $75.5M | +28% |
| Q3 2025 | $54.5M | -32% |
| Q2 2025 | $52.4M | +11% |
| Q1 2025 | $46.0M | +5% |
From Puma Biotechnology's 8-K filed Nov 5, 2026 (on EDGAR).
Questions
How does Puma Biotechnology make money?
Puma Biotechnology (PBYI) made $55.1M of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. Product revenue, net brought in $54.1M (98%); Royalty revenue brought in $1.0M (2%). Of every dollar of revenue, 10¢ was left as operating profit, 11¢ was left as net earnings.
What is Puma Biotechnology's biggest business?
Product revenue, net: $54.1M in the third quarter 2026, 98% of revenue, +4% from a year earlier.
What is Puma Biotechnology's profit margin?
Net earnings were $6.0M, 10.9% of revenue, in the third quarter 2026; the operating margin was 9.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.